UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
June 2,
2008
Date of
Report (Date of earliest event reported)
TAPIMMUNE
INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
000-27239
|
88-0277072
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
Unit 2 – 3590 West
41st
Avenue,
Vancouver, British
Columbia, Canada
|
V6N
3E6
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(604)
264-8274
Registrant’s
telephone number, including area code
N/A
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following
provisions:
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
__________
SECTION
8 – OTHER EVENTS
|
Item
8.01
|
Other
Events
|
As of
June 2, 2008, TapImmune Inc. (the “Company”) had fully repaid a loan evidenced
by certain secured promissory notes, which loan arrangement that Company had
entered into with various secured parties on December 3, 2007, as described in
the Company’s Current Report on Form 8-K as filed with the Securities and
Exchange Commission on December 6, 2007.
SECTION
9 – FINANCIAL STATEMENTS AND EXHIBITS
Item
9.01 Financial Statements and
Exhibits.
(a) Financial
statements of business acquired.
Not
applicable.
(b) Pro
forma financial information.
Not
applicable.
(c) Shell
company transactions.
Not
applicable.
(d) Exhibits.
Not
applicable.
|
|
__________
|
-2-
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
TAPIMMUNE
INC.
|
|
|
DATE: June
5, 2008
|
By: /s/
Denis Corin
______________________________________
Denis
Corin
President,
Chief Executive Officer and Principal Executive
Officer
|
__________
|
|
-3-
|